Mapping the burden of onchocercal skin disease*
Author:
- 17 April 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (2) , 199-207
Abstract
Onchocerciasis is a neglected tropical disease caused by a nematode parasite, Onchocerca volvulus, and transmitted by bites of Simulium blackflies which breed near fast‐flowing rivers. In humans thousands of microfilariae (immature worms) migrate to the skin and eyes where they cause pathology. Historically, much research was devoted to the serious effect of blindness, from which the disease earns its alternative name of "river blindness". Mapping the burden of onchocercal skin disease (OSD) was expedited by the development of a clinical classification and grading system which facilitated comparison of data from different countries. After successful field‐testing in Nigeria, the classification scheme was used in a multicountry study in seven endemic sites, to estimate the true burden of OSD across Africa. High levels of OSD were found, affecting 28% of the population. A new control programme, the African Programme for Onchocerciasis Control (APOC) was launched in 20 countries using annual doses of ivermectin, donated by Merck & Co., Inc. The multicountry study also found a close correlation between the levels of itching and OSD with the level of endemicity, as determined by the prevalence of onchocercal nodules. This enabled APOC to use Rapid Epidemiological Mapping of Onchocerciasis (REMO) which entailed identifying likely vector breeding sites near rivers, then sampling 50 adult males in nearby villages to determine the prevalence of nodules and delineate which villages required treatment. Onchocerciasis is now targeted for elimination in Africa, and the challenge is to complete Onchocerciasis Elimination Mapping (OEM) of hypoendemic areas using serology.Keywords
This publication has 55 references indexed in Scilit:
- Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and SenegalPLOS Neglected Tropical Diseases, 2012
- Changes in stigma and discrimination of onchocerciasis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2012
- Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis ControlParasites & Vectors, 2012
- The Geographic Distribution of Loa loa in Africa: Results of Large-Scale Implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)PLOS Neglected Tropical Diseases, 2011
- The African Programme for Onchocerciasis Control: impact on onchocercal skin diseaseTropical Medicine & International Health, 2011
- Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?BMC Medical Genetics, 2010
- Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and SenegalPLOS Neglected Tropical Diseases, 2009
- Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in CameroonParasites & Vectors, 2009
- The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trialTropical Medicine & International Health, 1998
- ON THE PRESENCE OF A FILARIA IN "CRAW-CRAW."The Lancet, 1875